GL1X · GenesisL1 explorer

MolNFT v1 · #161018 · protein

Crystal structure of ldha in complex with compound NCGC00420737-09 at 2.00 a resolution

6Q13: “Crystal structure of ldha in complex with compound NCGC00420737-09 at 2.00 a resolution”. X-ray diffraction, 2 ligands (NAI, P8V). MolNFT v1 #161018 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6Q13
Type
protein
Length
1,324 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P00338
Ligands
NAI, P8V

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, D—protein331—P00338

Ligands and binding sites

  • NAI · 1,4-dihydronicotinamide adenine dinucleotide · ligand · 4 copies · chains A, B, C, D
  • P8V · 2-[5-(cyclopropylmethyl)-4-[(3-fluoro-4-sulfamoylphenyl)methyl]-3-{3-[(5-methylthiophen-2-yl) ethynyl]phenyl}-1H-pyrazol-1-yl]-1,3-thiazole-4-carboxylic acid · ligand · 4 copies · chains A, D, B, C
  • EDO · 1,2-ethanediol · additive · 14 copies · chains A, C, B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6Q13 · Crystal structure of ldha in complex with compound NCGC00420737-09 at 2.00 a resolution · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.